Geographical Group Reporting Submission
Cochrane US (American College of Physicians)
Kate Carroll
Living Clinical Guideline and Living Systematic Review and Network Meta-Analysis on Treatments for Adults with Major Depressive Disorder
Cochrane Austria
Yes
ACP Center for Evidence Reviews at Cochrane Austria/University for Continuing Education Krems (Danube University Krems)
Kate Carroll
kcarroll@acponline.org
kcarroll@acponline.org
Evidence production, Dissemination / Knowledge Translation, Written report or publication
The clinical guideline and evidence reviews were published in Annals of Internal Medicine. The most recent (2022) Impact Factor for Annals of Internal Medicine is 39.2 (Clarivate Analytics). Annals is the most cited general internal medicine journal and one of the most influential journals in the world.
The clinical guideline and systematic review, respectively, have Altmetric Attention Scores of 311 (99th percentile compared to outputs of similar age) and 15 (89th percentile compared to outputs of similar age).
Link to systematic review and network meta-analysis: https://www.acpjournals.org/doi/10.7326/M22-1845
Link to rapid review on values and preferences of patients with depressive disorder: https://www.acpjournals.org/doi/10.7326/M22-1900
Link to rapid review on cost-effectiveness of treatment strategies for major depressive disorder: https://www.acpjournals.org/doi/10.7326/m22-1872
The clinical guideline and systematic review, respectively, have Altmetric Attention Scores of 311 (99th percentile compared to outputs of similar age) and 15 (89th percentile compared to outputs of similar age).
Link to systematic review and network meta-analysis: https://www.acpjournals.org/doi/10.7326/M22-1845
Link to rapid review on values and preferences of patients with depressive disorder: https://www.acpjournals.org/doi/10.7326/M22-1900
Link to rapid review on cost-effectiveness of treatment strategies for major depressive disorder: https://www.acpjournals.org/doi/10.7326/m22-1872